Advanced Soft Tissue Sarcoma clinical trials

Explore recruiting advanced soft tissue sarcoma clinical trials.

Recruiting advanced soft tissue sarcoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Soft Tissue Sarcoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Randomized, Phase 3 Study to Assess the Efficacy and Safety of INtratumorally Administered INT230-6 (SHAO, VINblastine, CIsplatin) Compared With US Standard of Care in Adult Participants With Locally Recurrent, InoperaBLE, or Metastatic Soft Tissue Sarcomas - (THE INVINCIBLE-3 TRIAL)

Spain, France, Poland, Germany, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase I/II randomized clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Phase I/II randomized clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase I/IIa study of intra-tumoral BT-001 (TG6030) administered alone, and in combination with pembrolizumab in patients with cutaneous or, subcutaneous lesions or, easily injectable lymph nodes of metastatic/advanced solid tumors.

Belgium, France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Advanced Soft Tissue Sarcoma trials by city

Advanced Soft Tissue Sarcoma clinical trials

Recruiting advanced soft tissue sarcoma studies right now

NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma

APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors

Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer

A Study of MGC026 in Participants With Advanced Solid Tumors

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas

A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma

Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Also recruiting in Europe

A Multicenter, Randomized, Phase 3 Study to Assess the Efficacy and Safety of INtratumorally Administered INT230-6 (SHAO, VINblastine, CIsplatin) Compared With US Standard of Care in Adult Participants With Locally Recurrent, InoperaBLE, or Metastatic Soft Tissue Sarcomas - (THE INVINCIBLE-3 TRIAL)

Phase I/II randomized clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas

Phase I/II randomized clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas

A Phase I/IIa study of intra-tumoral BT-001 (TG6030) administered alone, and in combination with pembrolizumab in patients with cutaneous or, subcutaneous lesions or, easily injectable lymph nodes of metastatic/advanced solid tumors.

Advanced Soft Tissue Sarcoma trials by city

Other conditions